SDC Partners with Singular to Advance Secure AI Solutions in Healthcare
January 31, 2025 15:11 ET
|
SDC Clinical
SDC has partnered with Singular exclusively to integrate secure closed-loop AI capabilities into clinical research technology offerings.
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
January 31, 2025 11:59 ET
|
Aclarion, Inc.
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
SAB BIO to Participate in Upcoming Investor Conferences
January 31, 2025 07:00 ET
|
SAB Biotherapeutics, Inc.
MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing...
Rakovina Therapeutics Announces Listing on Frankfurt Stock Exchange
January 30, 2025 12:16 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel...
Liberation Labs Closes $50.5 Million Convertible Note
January 30, 2025 08:00 ET
|
Liberation Labs
RICHMOND, Ind., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has closed a convertible note with $31.5 million in new capital, which, combined with $19 million of insider bridge notes raised...
Silexion Therapeutics Announces Exercise of Warrants for $3.3 Million Gross Proceeds
January 29, 2025 17:30 ET
|
Silexion Therapeutics Corp
Cayman Islands, January 29, 2025 -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for...
PharmAla Issues Q1 Financial Statements
January 29, 2025 16:10 ET
|
PharmAla Biotech
PharmAla releases its Q1 financial statements
Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference
January 29, 2025 08:30 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer therapies through artificial...
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
January 29, 2025 08:00 ET
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
Compass Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
January 29, 2025 08:00 ET
|
Compass Therapeutics
BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...